Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 29/11/2020
SIETES contiene 93170 citas

 
 
 1 a 20 de 38 siguiente >>
Presentar resultados
Seleccionar todas
2.Enlace a cita original Cita con resumen
Biagi C, Conti V, Montanaro N, Melis M, Buccellato E, Donati M, Covezzoli A, Amato R, Pazzi L, Venegoni M, Vaccheri A, Motola D. Comparative safety profiles of intravitreal bevacizumab, ranibizumab and pegaptanib: the analysis of the WHO database of adverse drug reactions. Eur J Clin Pharmacol 2014;70:1505-12. [Ref.ID 98418]
3.Enlace a cita original
Biagi C, Venegooni M, Melis M, Buccellato E, Montanaro N, Motola D. Dronedarone-associated acute renal failure: evidence coming from the Italian spontaneous ADR reporting database. Br J Clin Pharmacol 2013;75:1351-5. [Ref.ID 95329]
4.Enlace a cita original
Roberto G, Biagi C, Montanaro N, Koci A, Moretti U, Motola D. Statin-associated gynecomastia: evidence coming from the Italian spontaneous ADR reporting database and literature. Eur J Clin Pharmacol 2012;68:1007-11. [Ref.ID 93106]
5.
Lapi F, Tucori M, Motola D, Pugi A, Vietri M, Montanaro N, Vaccheri A, Leoni O, Cocci A, Leone R, Conforti A, Moretti U, Sessa E, Mazzaglia G, Mugelli A, Mazzei T, Vannacci A. Safety profile of the fluoroquinolones: analysis of adverse drug reactions in relation to prescription data using four regional pharmacovigilance databases in Italy. Drug Saf 2010;33:789-99. [Ref.ID 89273]
6.Enlace a cita original
Chiabrando G, Bianchi S, Poluzzi E, Montanaro N, Scanavacca P. Profile of atypical-antipsychotics use in patients affected by dementia in the University Hospital of Ferrara. Eur J Clin Pharmacol 2010;66:661-9. [Ref.ID 88814]
7.Enlace a cita original
Piccinni C, Sacripanti C, Poluzzi E, Motola D, Magro L, Moretti U, Conforti A, Montanaro N. Stronger association of drug-induced progressive multifocal leukoencephalopathy (PML) with biological immunomodulating agents. Eur J Clin Pharmacol 2010;66:199-206. [Ref.ID 87678]
8. Cita con resumen
Poluzzi E, Strahinja P, Lanzoni M, Vargiu A, Silvani MC, Motola D, Gaddi A, Vaccheri A, Montanaro N. Adherence to statin therapy and patients' cardiovascular risk: a pharmacoepidemiological study in Italy. Eur J Clin Pharmacol 2008;64:425-32. [Ref.ID 82633]
9. Cita con resumen
Poluzzi E, Strahinja P, Vaccheri A, Vargiu A, Silvani MC, Motola D, Marchesini G, De Ponti F, Montanaro N. Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage. Br J Clin Pharmacol 2007;63:346-55. [Ref.ID 79456]
10. Cita con resumen
Motola D, Vargiu A, Leone R, Cocci A, Salvo F, Ros B, Meneghelli I, Venegoni M, Cutroneo PM, Vaccheri A, Velo G, Montanaro N. Hepatic adverse drug reactions: a case/non-case study in Italy. Eur J Clin Pharmacol 2007;63:73-9. [Ref.ID 79050]
11. Cita con resumen
Motola D, De Ponti F, Poluzzi E, Martini N, Rossi P, Silvani MC, Vaccheri A, Montanaro N. An update on the first decade of the European centralized procedure: how many innovative drugs?. Br J Clin Pharmacol 2006;62:610-6. [Ref.ID 78427]
12.
Poluzzi E, Strahinja P, Vargiu A, Chiabrando G, Silvani MC, Motola D, Cellini GS, Vaccheri A, De Ponti F, Montanaro N. nitital treatment of hypertension and adherence to therapy in general practice in Italy. Eur J Clin Pharmacol 2005;61:603-9. [Ref.ID 75026]
13.
Leone R, Conforti A, Venegoni M, Motola D, Moretti U, Meneghelli I, Cocci A, Cellini GS, Scotto S, Montanaro N, Velo G. Drug-induced anaphylaxis: case/non-case study based on an Italian pharmacovigilance database. Drug Saf 2005;28:547-56. [Ref.ID 74171]
14. Cita con resumen
Motola D, De Ponti F, Rossi P, Martini N, Montanaro N. Therapeutic innovation in the European Union: analysis of the drugs approved by the EMEA between 1995 and 2003. Br J Clin Pharmacol 2005;59:475-8. [Ref.ID 73535]
15.
Motola D, Vaccheri A, Silvani MC, Poluzzi E, Bottoni A, De Ponti F, Montanaro N. Pattern of NSAID use in the Italian general population: a questionnaire-based survey. Eur J Clin Pharmacol 2004;60:731-8. [Ref.ID 72310]
16. Cita con resumen
Poluzzi E, Motola D, Silvani C, De Ponti F, Vaccheri A, Montanaro N. Prescriptions of antidepressants in primary care in Italy: pattern of use after admission of selective serotonin reuptake inhibitors for reimbursement. Eur J Clin Pharmacol 2004;59:825-31. [Ref.ID 68901]
17.
Leone R, Venegoni M, Motola D, Moretti U, Piazzetta V, Cocci A, Resi D, Mozzo F, Velo G, Burzilleri L, Montanaro N, Conforti A. Adverse drug reactions related to the use of fluoroquinolone antimicrobials: an analysis of spontaneous reports and fluoroquinolone consumption data from three Italian regions. Drug Saf 2003;26:109-20. [Ref.ID 64867]
18. Cita con resumen
De Ponti F, Poluzzi E, Vaccheri A, Bergman U, Bjerrum L, Ferguson J, Frenz KJ, McManus P, Schubert I, Selke G, Terzis-Vaslamatzis G, Montanaro N. Non-antiarrhythmic drugs prolonging the QT interval: considerable use in seven countries. Br J Clin Pharmacol 2002;54:171-7. [Ref.ID 63048]
19.
De Ponti F, Poluzzi E, Cavalli A, Recanatini M, Montanaro N. Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: an overview. Drug Saf 2002;25:263-86. [Ref.ID 61881]
20. Cita con resumen
Poluzzi E, Resi D, Zuccheri P, Motola D, De Ponti F, Vaccheri A, Montanaro N. Use of anti-asthmatic drugs in Italy: analysis of prescriptions in general practice in the light of guidelines for asthma treatment. Eur J Clin Pharmacol 2002;58:55-9. [Ref.ID 61624]
Seleccionar todas
 
 1 a 20 de 38 siguiente >>